Profile data is unavailable for this security.
About the company
Innovita Biological Technology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of point-of-care testing (POCT) rapid diagnostic products. The Company's main products include novel coronavirus (2019-nCoV) neutralizing antibody detection kits using colloidal gold, quantum dot fluorescence immunochromatography and chemiluminescence techniques, and respiratory pathogen detection products, such as whole blood respiratory quintuple detection card, influenza virus triple detection card, virus serum quintuple detection card, respiratory pathogen nine indirect immunofluorescence kit, and others.
- Revenue in CNY (TTM)720.40m
- Net income in CNY332.01m
- Incorporated2006
- Employees404.00
- LocationInnovita Biological Technology Co LtdBEIJING 100071ChinaCHN
- Phone+86 1 083682249
- Fax+86 1 083682966
- Websitehttps://www.innovita.com.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hangzhou Ags Medtech Co Ltd | 590.12m | 271.52m | 5.01bn | 592.00 | 18.45 | 2.17 | -- | 8.50 | 3.36 | 3.36 | 7.30 | 28.53 | 0.2545 | 3.27 | 13.92 | 996,828.30 | 11.71 | -- | 12.26 | -- | 71.52 | -- | 46.01 | -- | 19.56 | -- | 0.003 | -- | 37.09 | -- | 49.87 | -- | -- | -- |
| Xiangyu Medical Co Ltd | 709.56m | 121.39m | 5.14bn | 1.82k | 41.73 | 2.54 | -- | 7.25 | 0.77 | 0.77 | 4.52 | 12.66 | 0.2596 | 1.01 | 14.80 | 390,085.10 | 4.44 | 11.18 | 5.62 | 13.12 | 66.03 | 66.78 | 17.12 | 32.69 | 1.43 | -- | 0.1417 | 27.33 | 52.46 | 15.72 | 81.03 | 23.11 | 132.76 | -- |
| Hangzhou Alltest Biotech Co Ltd | 812.78m | 276.54m | 5.33bn | 1.09k | 19.21 | 1.34 | -- | 6.55 | 3.50 | 3.50 | 10.26 | 50.02 | 0.198 | 2.21 | 6.97 | 743,626.50 | 6.74 | 23.35 | 7.22 | 26.83 | 53.69 | 58.34 | 34.03 | 39.07 | 10.46 | -- | 0.0022 | 29.79 | -77.73 | 32.59 | -84.75 | 26.19 | 72.77 | -- |
| Shanghai Sanyou Medical Co Ltd | 434.20m | 37.87m | 5.36bn | 466.00 | 150.61 | 2.80 | -- | 12.34 | 0.1432 | 0.1432 | 1.71 | 7.69 | 0.1951 | 0.6191 | 5.15 | 931,756.40 | 2.09 | 9.42 | 2.41 | 10.85 | 70.72 | 87.15 | 10.73 | 29.78 | 3.27 | -- | 0.0135 | 16.21 | -29.08 | 15.67 | -49.91 | 8.99 | -15.60 | -- |
| Innovita Biological Technology Co Ltd | 720.40m | 332.01m | 5.87bn | 404.00 | 17.61 | 2.87 | -- | 8.15 | 2.44 | 2.44 | 5.30 | 14.98 | 0.3584 | 3.18 | 9.16 | 1,783,177.00 | 16.52 | -- | 17.42 | -- | 80.70 | -- | 46.09 | -- | 16.01 | -- | 0.001 | -- | 7.03 | -- | 15.44 | -- | -- | -- |
| Zhende Medical Co Ltd | 4.04bn | 205.34m | 6.17bn | 6.72k | 30.13 | 1.11 | -- | 1.53 | 0.7684 | 0.7684 | 15.19 | 20.95 | 0.5191 | 3.12 | 6.43 | 601,941.30 | 2.85 | 17.13 | 3.61 | 23.54 | 34.16 | 38.05 | 5.49 | 17.33 | 1.80 | 38.53 | 0.1465 | 29.85 | -32.76 | 23.63 | -70.87 | 8.79 | 21.46 | 47.58 |
| Zhejiang Orient Gene Biotech Co Ltd | 825.60m | -587.36m | 6.72bn | 2.23k | -- | 0.9766 | -- | 8.14 | -2.93 | -2.93 | 4.14 | 34.13 | 0.0949 | 1.17 | 3.19 | 370,058.00 | -7.18 | 29.62 | -8.27 | 38.29 | 39.26 | 59.69 | -75.73 | 35.82 | 3.71 | -- | 0.0744 | 19.24 | -90.65 | 23.46 | -119.23 | -- | 121.04 | -- |
Data as of Sep 13 2024. Currency figures normalised to Innovita Biological Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
57.69%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 7.78m | 26.02% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 3.07m | 10.27% |
| CITIC Securities Co., Ltd. (Invt Port)as of 30 Jun 2024 | 2.01m | 6.72% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2024 | 948.41k | 3.17% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2024 | 872.57k | 2.92% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 764.68k | 2.56% |
| ABC-CA Fund Management Co., Ltd.as of 30 Jun 2024 | 663.58k | 2.22% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 472.02k | 1.58% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2024 | 397.83k | 1.33% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 266.58k | 0.89% |
More ▼
Data from 30 Jun 2024 - 27 Sep 2024Source: FactSet Research Systems Inc.
